Advertisement

CardioVasc

, Volume 19, Issue 2, pp 47–53 | Cite as

Was ist neu und praxisrelevant?

Europäische myokardiale Revaskularisationsleitlinie 2018

  • Sebastian KufnerEmail author
  • Adnan Kastrati
Zertifizierte Fortbildung Schwerpunkt Kardiologie
  • 95 Downloads

Zusammenfassung

Ziel einer Myokardrevaskularisation bei Patienten mit KHK ist die Verbesserung persistierender Symptome und der Prognose. Der Erfolg hängt stark von der Vollständigkeit der Revaskularisation ab. Die anatomische Komplexität und das Vorliegen von Komorbiditäten wie Diabetes mellitus bestimmen maßgeblich die relativen Vorteile von PCI und Bypass-Operation. Im Fall einer PCI sollte diese über einen transradialen Zugangsweg mit Implantation eines DES der neuen Generation erfolgen.

Literatur

  1. 1.
    Neumann FJ, Sousa-Uva M, Ahlsson A et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165CrossRefGoogle Scholar
  2. 2.
    Davies JE, Sen S, Dehbi HM et al. Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI. N Engl J Med. 2017;376(19):1824–34CrossRefGoogle Scholar
  3. 3.
    Gotberg M, Christiansen EH, Gudmundsdottir IJ et al. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med. 2017;376(19):1813–23CrossRefGoogle Scholar
  4. 4.
    Velazquez EJ, Lee KL, Jones RH et al. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. N Engl J Med. 2016;374(16):1511–20CrossRefGoogle Scholar
  5. 5.
    Jolly SS, Yusuf S, Cairns J et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011;377(9775):1409–20CrossRefGoogle Scholar
  6. 6.
    Valgimigli M, Gagnor A, Calabro P et al. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet. 2015;385(9986):2465–76CrossRefGoogle Scholar
  7. 7.
    Prati F, Di Vito L, Biondi-Zoccai G et al. Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l’Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study. EuroIntervention. 2012;8(7):823–9CrossRefGoogle Scholar
  8. 8.
    Meneveau N, Souteyrand G, Motreff P et al. Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS Study (Does Optical Coherence Tomography Optimize Results of Stenting). Circulation. 2016;134(13):906–17CrossRefGoogle Scholar
  9. 9.
    Cassese S, Byrne RA, Ndrepepa G et al. Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials. Lancet. 2016;387(10018):537–44CrossRefGoogle Scholar
  10. 10.
    Baim DS, Wahr D, George B et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002;105(11):1285–90CrossRefGoogle Scholar
  11. 11.
    Brennan JM, Al-Hejily W, Dai D et al. Three-year outcomes associated with embolic protection in saphenous vein graft intervention: results in 49 325 senior patients in the Medicare-linked National Cardiovascular Data Registry CathPCI Registry. Circ Cardiovasc Interv. 2015;8(3):e001403CrossRefGoogle Scholar
  12. 12.
    Paul TK, Bhatheja S, Panchal HB et al. Outcomes of Saphenous Vein Graft Intervention With and Without Embolic Protection Device: A Comprehensive Review and Meta-Analysis. Circ Cardiovasc Interv. 2017;10(12);  https://doi.org/10.1161/CIRCINTERVENTIONS.117.005538
  13. 13.
    Thiele H, Akin I, Sandri M et al. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. N Engl J Med. 2017;377(25):2419–32CrossRefGoogle Scholar
  14. 14.
    Valgimigli M, Bueno H, Byrne RA et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2018;53(1):34–78CrossRefGoogle Scholar
  15. 15.
    Sibbing D, Aradi D, Jacobshagen C et al. Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial. Lancet. 2017;390(10104):1747–57CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Deutsches Herzzentrum MünchenMünchenDeutschland

Personalised recommendations